Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ANG Lifesciences India has closed its trading window from 1st October 2025 until 48 hours after the company declares its unaudited financial results for the quarter and half year ending 30th September 2025. The closure applies to insiders, designated persons, and their immediate relatives, as required under SEBI's insider trading regulations. This is a standard compliance step taken ahead of the company announcing its Q2 and H1 FY26 earnings. The exact date of the board meeting to approve these results will be communicated separately.
This is a routine regulatory filing and does not affect shareholders directly. However, it signals that the company's Q2 and H1 FY26 results are expected in the coming weeks, which investors should watch for as it may influence the stock price.